卵巢癌中介质素-6调节需要有针对性的策略:从批准到新兴疗法

Hina Amer1, Nirmala C Kampan2, Catherine Itsiopoulos1

  • 1School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3082, Australia.

Cancers
|January 8, 2025
PubMed
概括

干白素-6 (IL6) 驱动卵巢癌的进展和抵抗. 向IL6提供了一个有希望的治疗策略,以改善患者的治疗结果,并克服卵巢癌的治疗挑战.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K